Association of CD44 Isoform Immunohistochemical Expression with Myometrial and Vascular Invasion in Endometrioid Endometrial Carcinoma

Author： Stokes G.N. Shelton J.B. Zahn C.M. Kendall B.S.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.1, 2002-01, pp. : 58-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Expression Profile in Endometrioid Endometrial Carcinoma

By Gunter Kieback D. Fischer D.-C.

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma

By Nozoe T. Kohnoe S. Ezaki T. Kabashima A. Maehara Y.

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 6, 2004-06 ,pp. : 334-338

Springer Publishing Company

Access to resources Recommend Favorite

Clear Cell Carcinoma of the Ovary: Characterization of Its CD44 Isoform Repertoire

By Sancho-Torres I. Mesonero C. Miller Watelet J.-L. Gibbon D. Rodriguez-Rodriguez L.

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 187-195

Elsevier

Access to resources Recommend Favorite

Adjunctive Use of the Uterine Artery Resistance Index in the Preoperative Prediction of Myometrial Invasion in Endometrial Carcinoma

By Develioglu O.H. Bilgin T. Yalcin O.T. Ozalp S. Ozan H.

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 26-31

Elsevier

Access to resources Recommend Favorite

CD44 Isoform 6 (CD44v6) Is a Prognostic Indicator of the Response to Neoadjuvant Chemotherapy in Cervical Carcinoma

By Costa S. Terzano P. Bovicelli A. Martoni A. Angelelli B. Santini D. Ceccarelli C. Lipponen P. Erzen M. Syrjanen S. Syrjanen K.

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 67-73

Elsevier

Access to resources Recommend Favorite